Mayr et al. synthesized platinum (IV) complexes conjugated with an EGFR-targeting peptide, LARLLT; however, it was found to be unsuitable for increasing the specific uptake of small-molecule drugs in cancer cells with overexpressed EGFR [130]. This evidence concerns the gene EGFR and cancer.